Dr. George Leung's research focuses on herbal medicine, especially medicinal mushrooms, on ageing-related problems such as cardiovascular disorders, neurodegenerative diseases and cancer.

Prof. Yan Wang, director of the Department of Drug Metabolism and Pharmacokinetics, and the Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD Study in Institute of Materia Medica, Chinese Academy of Medical Sciences, has long been engaged in the research of DMPK and pharmacology concerning the intestinal bacteria. Prof. Yan Wang focuses the following researching fields: 1) intestinal bacteria and natural drug interactions; 2) the conversion and metabolism of natural medicines and natural active ingredients based on intestinal microbiota; 3) the mechanism of clinical chronic diseases and personalized treatment based on intestinal microbiota and has established a serial of key technologies investigating interaction between natural products and intestinal bacteria by applying the multi-omics technology.

Jocelin Chan – PhD, B. Pharm (1st class honours) is a research associate at the University of Sydney School of Pharmacy. She is also a practicing community pharmacist and a pharmacy owner. Jocelin’s research interests include drug-herb interactions; the use of Annona muricata (Graviola) in people living with cancer; quality use of complementary medicines, and the quality of herbal medicine products. She contributes to the development and review of monographs to resource healthcare professionals with evidence-based knowledge about drug-herb interactions. Her recent research includes evaluating the safety and tolerability of a herbal product (Annona muricata) through a clinical study in collaboration with Concord Cancer Centre, Sydney Australia.

Tom earned a Master's in Biochemistry from the University of Otago (New Zealand) in 2013 and has since worked in translational research labs worldwide. For the last few years, he has been assisting in clinical trials related to acute leukemias at the Alfred Hospital in Melbourne, Australia. Tom joined Elita in early 2025 where he has been leading the development of cell-based therapies using adipose-derived mesenchymal stem cells from dogs. Elita is Australia's only stem cell bank for pets and Tom's presentation will highlight how extracellular vesicles (EVs) from adipose-derived mesenchymal stem cells (ADMSCs) could serve as biomarkers for longevity in canines.

Associate professor Thuan Thi Minh Nguyen obtained Master's degree in pharmacy with specialization in drug quality control - Toxicology from University of Medicine and Pharmacy at Ho Chi Minh City (UMP) in 2007. In 2015, she obtained Doctor’s degree in biomedical and pharmaceutical sciences from Université Catholique de Louvain in Brussels in Belgium. She is currently senior lecturer and deputy head of Department of Biochemistry at Faculty of Pharmacy – UMP, Ho Chi Minh City, Viet Nam. She has more than 52 publications on biochemistry, toxicology, and clinical biochemistry.

Dr. Yoshimichi Sai is Professor and Director of Department of Hospital Pharmacy, Kanazawa University. He received his B.S. (1989) in Pharmaceutics and his M.S. (1991) and Ph.D. (1994) in Biochemistry from the Kanazawa University. He is a faculty member of Graduate School of Medical Sciences, Kanazawa University. Prof. Sai is the (co)-author of more than 200 research articles, reviews, book chapter, 150 invited lectures and more than 500 abstracts presented domestic and international conferences. He was awarded the Young Investigator Award, Japanese Society for the Study of Xenobiotics in 2004, the Young Investigator Award 2002 of the Pharmaceutical Society of Japan, Hokuriku branch and the Japanese Society of Pharmaceutical Health Care and Sciences Award. He is one of the Vice President of the Japanese Society of Pharmaceutical Health Care and Sciences.